The preliminary results looked great. Combined with low rate of side-effects and higher storage temp (2-8 C), it could have been a good 2nd (or 3rd) choice for the developing world.
https://www.nih.gov/news-events/news-releases/us-clinical-tr...
Basically, there are still more questions than answers in my mind. I just hope the national countermeasure compensation fund will be able to handle any potential fallout.
So it's mostly a concern that in one way we are targeting a spike protein on out own cell, but normally a virus would be complete and not be displayed as part of the cell wall. That's where I wonder if some people's immune system might code off of other normal proteins in addition to the spike. I would have thought there would at least have been a study about autoimmune antibody levels. I found one about severe covid patients having a higher likelihood of having them, but I couldn't find a study looking at the vaccines. It's pretty frustrating that I'm being downvoted for asking what I think is a legitimate question, one that apparently hasn't been looked into (since I can't find any study and the downvoters haven't provided one either).
Every day we can get any approval sooner is so many lives saved!